Detalhe da pesquisa
1.
Influence of Preseason Antibodies Against Influenza Virus on Risk of Influenza Infection Among Healthcare Personnel.
J Infect Dis
; 225(5): 891-902, 2022 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34534319
2.
Risk Factors for Healthcare Personnel Infection With Endemic Coronaviruses (HKU1, OC43, NL63, 229E): Results from the Respiratory Protection Effectiveness Clinical Trial (ResPECT).
Clin Infect Dis
; 73(11): e4428-e4432, 2021 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32645144
3.
Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus-associated illnesses.
J Med Virol
; 92(5): 512-517, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32073157
4.
N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical Trial.
JAMA
; 322(9): 824-833, 2019 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31479137
5.
Interpatient mutational spectrum of human coronavirus-OC43 revealed by illumina sequencing.
J Med Virol
; 89(8): 1330-1338, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28191658
6.
The Respiratory Protection Effectiveness Clinical Trial (ResPECT): a cluster-randomized comparison of respirator and medical mask effectiveness against respiratory infections in healthcare personnel.
BMC Infect Dis
; 16: 243, 2016 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27255755
7.
Preschool-Aged Household Contacts as a Risk Factor for Viral Respiratory Infections in Healthcare Personnel.
Open Forum Infect Dis
; 10(2): ofad057, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36824623
8.
A phase 1 dose-sparing, randomized clinical trial of seasonal trivalent inactivated influenza vaccine combined with MAS-1, a novel water-in-oil adjuvant/delivery system.
Vaccine
; 40(9): 1271-1281, 2022 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35125219
9.
MAS-1, a novel water-in-oil adjuvant/delivery system, with reduced seasonal influenza vaccine hemagglutinin dose may enhance potency, durability and cross-reactivity of antibody responses in the elderly.
Vaccine
; 40(10): 1472-1482, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35125224
10.
Impact of mandatory vaccination of healthcare personnel on rates of influenza and other viral respiratory pathogens.
Infect Control Hosp Epidemiol
; 43(9): 1216-1220, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34350820
11.
Outpatient healthcare personnel knowledge and attitudes towards infection prevention measures for protection from respiratory infections.
Am J Infect Control
; 49(11): 1369-1375, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34182066
12.
Take-home kits to detect respiratory viruses among healthcare personnel: Lessons learned from a cluster randomized clinical trial.
Am J Infect Control
; 49(7): 893-899, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33581146
13.
Protecting Healthcare Personnel in Outpatient Settings: The Influence of Mandatory Versus Nonmandatory Influenza Vaccination Policies on Workplace Absenteeism During Multiple Respiratory Virus Seasons.
Infect Control Hosp Epidemiol
; 39(4): 452-461, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29514719
14.
Impact of a winter respiratory virus season on patients with COPD and association with influenza vaccination.
Chest
; 130(4): 1109-16, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17035445
15.
Coronavirus and Other Respiratory Illnesses Comparing Older with Young Adults.
Am J Med
; 128(11): 1251.e11-20, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26087047
16.
Safety and immunogenicity of a quadrivalent intradermal influenza vaccine in adults.
Vaccine
; 33(9): 1151-9, 2015 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25613721
17.
Recognizing influenza in older patients with chronic obstructive pulmonary disease who have received influenza vaccine.
Clin Infect Dis
; 36(2): 169-74, 2003 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12522748
18.
Immunogenicity and safety of Fluzone(®) intradermal and high-dose influenza vaccines in older adults ≥65 years of age: a randomized, controlled, phase II trial.
Vaccine
; 32(21): 2507-17, 2014 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24120672
19.
Phase I/II randomized trial of safety and immunogenicity of LIPO-5 alone, ALVAC-HIV (vCP1452) alone, and ALVAC-HIV (vCP1452) prime/LIPO-5 boost in healthy, HIV-1-uninfected adult participants.
Clin Vaccine Immunol
; 21(11): 1589-99, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25253665
20.
Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18-64 years of age.
Vaccine
; 31(19): 2358-65, 2013 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23499604